FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2021311952> ?p ?o ?g. }

• W2021311952 endingPage "290" @default.
• W2021311952 startingPage "289" @default.
• W2021311952 abstract "Primary amoebic meningoencephalitis (PAM) due to Naegleria fowleri is a fulminating infection that can result in death within days. The disease prognosis is poor, although early diagnosis and aggressive treatment might increase survival chances 1. Through contaminated water, N. fowleri enters nostrils and then migrates along the olfactory nerve, through the cribriform plate into the brain 2. PAM is characterized by parosmia, rapidly progressing to anosmia (with resultant ageusia) as the nerve cells of the olfactory bulbs are destroyed leading to seizures and finally death 3. Despite advances in antimicrobial chemotherapy and supportive case, the mortality rate associated with PAM has remained over 90% 1-3. A high mortality is attributed to (1) delayed diagnosis, (2) our incomplete understanding of the pathogenesis and pathophysiology of the disease, (3) lack of availability of safe and effective drugs, and (4) the difficulty in delivering anti-N. fowleri drugs to the brain. So far, only three survivors of PAM have been documented 4. These patients were treated with amphotericin B, rifampicin, fluconazole, dexamethasone, and phenytoin intravenous and/or intrathecally within first week of the infection 4, 5. A successful prognosis was attributed to early diagnosis (limited deeper tissue involvement), followed by aggressive antimicrobial chemotherapy. Both amphotericin B 5 and miltefosine 6 have been suggested as useful agents against PAM 7. The aim of this letter is to debate whether an improved therapeutic outcome can be achieved by administering drugs through the nasal cavity (proposed here as “transcribrial” route) against PAM (Figure 1)? The proposed intranasal route will deliver drugs across the cribriform plate (an anatomically porous bone) that is located at the roof of the nasal cavity. Due to the sieve like nature of the cribriform plate, the tips at the terminals of the proposed device with ball-valve function (one-way drug delivery) are designed to reach and deliver drugs in vaporized form to area of the brain (the inferior surface of the frontal lobe), a site where N. fowleri reaches and concentrates as its natural course of the disease, before spreading to the rest of the central nervous system (CNS). The underlying rationale for proposing such a portal is that many therapeutically desired drugs like amphotericin B fail to attain minimum inhibitory concentration (MIC) in the CNS, when administered systemically 8. The proposed route will be advantageous in that it will (1) bypass selectivity of the blood–brain barrier that limits drug permeability to the brain tissue, (2) trail the natural route of entry of N. fowleri into the brain, (3) target the site of infection, (4) exert lethal effect of drugs by attaining MIC at a lower dose without venous drainage, (5) avoid adverse effects due to systemic administration. Olfactory targeting through intranasal delivery would provide access to the CNS without affecting the integrity of the blood–brain barrier 9. This can be achieved through the use of a modified intranasal instrument (US Patent- 8146587 B2). We propose that this instrument should be modified to extend its nasal terminals so it can reach porous cribriform plate (Figure 1). Additionally, ball-valve effect should be added to the tip of the modified device so that to deliver the drug in vaporized form and prevent regurgitation to the flow system (Figure 1). The proposed route offers clear benefits over the conventional intravenous route, in that it would enable the use of water soluble drugs 10 to attain MIC at the epicenter of infection, overcome the BBB hindrance, minimal adverse effects by enjoying the benefits of topical administration, and dose adjustment at a faster pace. Given that PAM patients are receiving adjuvant therapies including antiseizure, strong hypnotics, and even general anesthetics 10, patient compliance with the proposed route should not pose any concern. Further research will test the effectiveness of the proposed route to administer drugs in the management of PAM due to N. fowleri and possibly other pathogens causing brain infections. We are thankful to Misbah Mannan for technical support and helpful discussions. This work is supported by the Aga Khan University. The authors declare no conflict of interest." @default.
• W2021311952 created "2016-06-24" @default.
• W2021311952 creator A5016457785 @default.
• W2021311952 creator A5033070497 @default.
• W2021311952 date "2014-01-24" @default.
• W2021311952 modified "2023-10-10" @default.
• W2021311952 title "Novel Chemotherapeutic Strategies in the Management of Primary Amoebic Meningoencephalitis Due to<i>Naegleria fowleri</i>" @default.
• W2021311952 cites W1975287400 @default.
• W2021311952 cites W1987951206 @default.
• W2021311952 cites W2016365941 @default.
• W2021311952 cites W2020037351 @default.
• W2021311952 cites W2077093058 @default.
• W2021311952 cites W2083356192 @default.
• W2021311952 cites W2127687797 @default.
• W2021311952 cites W2162785848 @default.
• W2021311952 doi "https://doi.org/10.1111/cns.12225" @default.
• W2021311952 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6493040" @default.
• W2021311952 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24456292" @default.
• W2021311952 hasPublicationYear "2014" @default.
• W2021311952 type Work @default.
• W2021311952 sameAs 2021311952 @default.
• W2021311952 citedByCount "29" @default.
• W2021311952 countsByYear W20213119522014 @default.
• W2021311952 countsByYear W20213119522015 @default.
• W2021311952 countsByYear W20213119522016 @default.
• W2021311952 countsByYear W20213119522018 @default.
• W2021311952 countsByYear W20213119522019 @default.
• W2021311952 countsByYear W20213119522020 @default.
• W2021311952 countsByYear W20213119522021 @default.
• W2021311952 countsByYear W20213119522022 @default.
• W2021311952 crossrefType "journal-article" @default.
• W2021311952 hasAuthorship W2021311952A5016457785 @default.
• W2021311952 hasAuthorship W2021311952A5033070497 @default.
• W2021311952 hasBestOaLocation W20213119521 @default.
• W2021311952 hasConcept C126322002 @default.
• W2021311952 hasConcept C141071460 @default.
• W2021311952 hasConcept C142724271 @default.
• W2021311952 hasConcept C16005928 @default.
• W2021311952 hasConcept C2776694085 @default.
• W2021311952 hasConcept C2778311950 @default.
• W2021311952 hasConcept C2778607973 @default.
• W2021311952 hasConcept C2778621254 @default.
• W2021311952 hasConcept C2779134260 @default.
• W2021311952 hasConcept C2779548794 @default.
• W2021311952 hasConcept C2779629538 @default.
• W2021311952 hasConcept C2779926200 @default.
• W2021311952 hasConcept C2780401358 @default.
• W2021311952 hasConcept C2781069245 @default.
• W2021311952 hasConcept C2781155112 @default.
• W2021311952 hasConcept C3008058167 @default.
• W2021311952 hasConcept C524204448 @default.
• W2021311952 hasConcept C71924100 @default.
• W2021311952 hasConceptScore W2021311952C126322002 @default.
• W2021311952 hasConceptScore W2021311952C141071460 @default.
• W2021311952 hasConceptScore W2021311952C142724271 @default.
• W2021311952 hasConceptScore W2021311952C16005928 @default.
• W2021311952 hasConceptScore W2021311952C2776694085 @default.
• W2021311952 hasConceptScore W2021311952C2778311950 @default.
• W2021311952 hasConceptScore W2021311952C2778607973 @default.
• W2021311952 hasConceptScore W2021311952C2778621254 @default.
• W2021311952 hasConceptScore W2021311952C2779134260 @default.
• W2021311952 hasConceptScore W2021311952C2779548794 @default.
• W2021311952 hasConceptScore W2021311952C2779629538 @default.
• W2021311952 hasConceptScore W2021311952C2779926200 @default.
• W2021311952 hasConceptScore W2021311952C2780401358 @default.
• W2021311952 hasConceptScore W2021311952C2781069245 @default.
• W2021311952 hasConceptScore W2021311952C2781155112 @default.
• W2021311952 hasConceptScore W2021311952C3008058167 @default.
• W2021311952 hasConceptScore W2021311952C524204448 @default.
• W2021311952 hasConceptScore W2021311952C71924100 @default.
• W2021311952 hasIssue "3" @default.
• W2021311952 hasLocation W20213119521 @default.
• W2021311952 hasLocation W20213119522 @default.
• W2021311952 hasLocation W20213119523 @default.
• W2021311952 hasLocation W20213119524 @default.
• W2021311952 hasOpenAccess W2021311952 @default.
• W2021311952 hasPrimaryLocation W20213119521 @default.
• W2021311952 hasRelatedWork W1972207985 @default.
• W2021311952 hasRelatedWork W2021311952 @default.
• W2021311952 hasRelatedWork W2110589116 @default.
• W2021311952 hasRelatedWork W2121925718 @default.
• W2021311952 hasRelatedWork W2127687797 @default.
• W2021311952 hasRelatedWork W2171488210 @default.
• W2021311952 hasRelatedWork W2223808518 @default.
• W2021311952 hasRelatedWork W2953737538 @default.
• W2021311952 hasRelatedWork W4246773463 @default.
• W2021311952 hasRelatedWork W4386809846 @default.
• W2021311952 hasVolume "20" @default.
• W2021311952 isParatext "false" @default.
• W2021311952 isRetracted "false" @default.
• W2021311952 magId "2021311952" @default.
• W2021311952 workType "article" @default.